Home » Products » Cardiac Drugs » DEPLATT 75

DEPLATT 75

DEPLATT 75
DEPLATT 75
Send Inquiry
Product Code : 00158
Price And Quantity
  • Minimum Order Quantity
  • 1 Crore
  • Unit of Measure
  • Piece/Pieces
  • Price Range
  • 100.00 - 600.00 INR
Product Specifications
  • Drug Type
  • Specific Drug
  • Physical Form
  • Tablets
  • Function
  • Anti-Cancer
  • Dosage
  • 75 Mg
  • Suitable For
  • Adults
Product Description
Deplatt - PLAVIX (Deplatt bisulfate) is an inhibitor of ADP-evoked blood platelet accumulation that acts by direct suppression of adenosine diphosphate (ADP) costive to its receptor and of the resulting ADP-mediated stimulation of the glycoprotein GPIIb/IIIa complex. It is pointed for the diminution of thrombotic events as follows:
  •     Recent Stroke
  •     Recent MI
  •     Established Peripheral Arterial Disease For patients with a history of recent myocardial infarction (MI)

The medication has been shown to decrease the rate of a conjunctive endpoint of new ischemic stroke, new MI, and some other vascular deaths. Acute Coronary Syndrome for patients with chronic coronary thrombosis syndrome including patients who are to be medically treated as well as those who come with per-cutaneous coronary intercession, CABG. It has been also shown to make reduction in the rate of a conjunctive endpoint of MI, cardiovascular death, or stroke as well as the pace of a refractory ischemia, combined endpoint of cardiovascular death, stroke or MI. Deplatt is an anti-platelet that is usually utilized to cut off the risk of heart attack strokes.

Active ingredients: Clopidogrel.



Trade Information
  • Payment Terms
  • Cash in Advance (CID), Cash Advance (CA)
  • Supply Ability
  • 1 Crore Per Week
  • Delivery Time
  • 1 Week
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia

DHEER HEALTHCARE PRIVATE LIMITED
X


DHEER HEALTHCARE PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.